The evolution of how prisoners in substance-abuse programs communicate is a good indicator of whether they'll return to crime, new research has found.
In a small double-blind study, Johns Hopkins researchers report that a substantial majority of people suffering cancer-related anxiety or depression found considerable relief for up to six months from a single large dose of psilocybin -- the active compound in hallucinogenic 'magic mushrooms.'
Amphetamine may slow down the rise of temperature in the body and mask fatigue, which could allow athletes to run significantly longer but result in potentially dangerous overheating of muscles, according to a study.
Participation in a prevention program shown to remove the effects of poverty on brain development, according to 14-year study.
Scientists at the Scripps Research Institute have developed a vaccine that blocks the pain-numbing effects of the opioid drugs oxycodone (oxy) and hydrocodone (hydro) in animal models.
The rate of adolescents reporting a recent bout of clinical depression grew by 37 percent over the decade ending in 2014, with one in six girls reporting an episode in the past year, new Johns Hopkins Bloomberg School of Public Health-led research suggests.
Indiana University neuroscientist Andrea Hohmann took the stage at a press conference Nov. 14 in San Diego to discuss research conducted at IU that has found evidence that the brain's cannabis receptors may be used to treat chronic pain without the side effects associated with opioid-based pain relievers or medical marijuana.
Identifying more effective treatment strategies tailored to individual responses for patients overcoming addiction to cocaine is the focus of a new clinical trial at McGovern Medical School at The University of Texas Health Science Center at Houston (UTHealth).
Effectively promoting health-related behavior change needs to be a key component of health care research and policy. And while these problems extend throughout the population, they disproportionately impact economically disadvantaged populations and other vulnerable populations and represent a major contributor to health disparities. To share the latest research in effectively managing these problems, Stephen T. Higgins, Ph.D., UVM professor of psychiatry and director of the VCBH, collaborated with experts on a third annual special issue of Preventive Medicine.
Houston Methodist researchers have discovered a set of immune proteins that facilitate long-lasting immunity against malaria. In a study recently published in Immunity, researchers reported that elevated production of specific proteins regulating the immune system within 24 hours of infection was required for a resilient and sustained anti-malaria immunity in mice.